Valuation: Meso Numismatics, Inc.

Market Cap 594K 521K 480K 449K 843K 56.02M 860K 5.77M 2.23M 27.69M 2.23M 2.18M 96.01M P/E 2024
-0.06x
P/E 2025 -0.08x
Enterprise Value 19.21M 16.84M 15.52M 14.53M 27.25M 1.81B 27.82M 187M 72.19M 895M 72.12M 70.54M 3.1B EV / Sales 2024
4.68x
EV / Sales 2025 3.78x
Free-Float
84.91%
Yield 2024 *
-
Yield 2025 -
06-09 Regenerative Medical Technology Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
05-14 Regenerative Medical Technology Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
05-13 Regenerative Medical Technology Group Inc. Auditor Raises 'Going Concern' Doubt CI
11-19 Regenerative Medical Technology Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-19 Regenerative Medical Technology Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-20 Regenerative Medical Technology Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-15 Regenerative Medical Technology Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-04-14 Regenerative Medical Technology Group Inc. Auditor Raises 'Going Concern' Doubt CI
24-11-19 Regenerative Medical Technology Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-11-07 Regenerative Medical Technology Group Inc. Announces Upcoming Launch of its New Clinic, Set to Open on November 23, 2024 CI
24-08-14 Regenerative Medical Technology Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-08-13 Meso Numismatics, Inc. Announces Global Stem Cells Groups Launch of Revolutionary New Line of Peptides CI
24-05-20 Regenerative Medical Technology Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Manager TitleAgeSince
Chief Executive Officer 61 2020-06-26
Director TitleAgeSince
Director/Board Member 61 2019-11-26
Change 5-day change 1-year change 3-year change Capi.($)
-1.55%-1.96% - - 594K
-0.48%+8.75%-5.51%+0.91% 46.36B
+2.19%+9.81%+385.81%+632.13% 37.88B
+2.53%+13.90%+20.85%-10.61% 31.12B
+1.65%+2.98%+9.98%+55.42% 30.61B
-4.16%-4.44%+8.53%+16.06% 24.69B
-0.32%+14.36% - - 16.25B
+1.37%+15.67%+71.80%+134.14% 14.85B
+1.00%+9.67%+14.90%+21.88% 13.58B
+3.63%+6.97%+104.07%+107.62% 12.95B
Average +0.57%+7.85%+76.30%+119.69% 25.36B
Weighted average by Cap. +0.69%+7.66%+85.55%+138.80%

Financials

2024 2025
Net sales 4.11M 3.6M 3.32M 3.11M 5.83M 387M 5.95M 39.9M 15.44M 191M 15.42M 15.09M 664M 5.1M 4.47M 4.12M 3.86M 7.24M 481M 7.39M 49.54M 19.17M 238M 19.15M 18.73M 825M
Net income -5.56M -4.88M -4.5M -4.21M -7.89M -525M -8.06M -54.04M -20.91M -259M -20.89M -20.43M -899M -7.81M -6.85M -6.31M -5.91M -11.08M -737M -11.31M -75.89M -29.37M -364M -29.34M -28.69M -1.26B
Net Debt 18.88M 16.56M 15.26M 14.29M 26.79M 1.78B 27.35M 183M 70.98M 880M 70.91M 69.36M 3.05B 18.61M 16.32M 15.04M 14.08M 26.41M 1.76B 26.96M 181M 69.96M 868M 69.89M 68.36M 3.01B
Logo Meso Numismatics, Inc.
Regenerative Medical Technology Group Inc. is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary, Global Stem Cells Group (GSCG). GSCG is a provider of regenerative medicine solutions, dedicated to advancing healthcare through patient therapies. The Company operates a portfolio of network of clinics, research facilities, and training centers. It also distributes stem cells and other regenerative-based cell lines and equipment internationally and specializes in educating and training physicians in the area of regenerative medicine. Its services include certified training courses for physicians, manufacturing and sales of equipment and supplies, research and development of clinical protocols, regenerative medicine clinics for patients, regenerative medicine practitioners’ network, and turnkey stem cell processing center solutions. Through ISSCA, it conducts specialized training, certification, and hands-on workshops.
Employees
-